DK2039356T3 - Spytfremmende præparat omfattende en M3-muskarinagonist og en alfa-2-adrenerg antagonist - Google Patents

Spytfremmende præparat omfattende en M3-muskarinagonist og en alfa-2-adrenerg antagonist

Info

Publication number
DK2039356T3
DK2039356T3 DK08368017.3T DK08368017T DK2039356T3 DK 2039356 T3 DK2039356 T3 DK 2039356T3 DK 08368017 T DK08368017 T DK 08368017T DK 2039356 T3 DK2039356 T3 DK 2039356T3
Authority
DK
Denmark
Prior art keywords
alpha
adrenergic antagonist
muscarinic agonist
salivary
preparation
Prior art date
Application number
DK08368017.3T
Other languages
English (en)
Inventor
Isabelle Madinier
Original Assignee
Univ Nice Sophia Antipolis
Ct Hospitalier Universitaire Nice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nice Sophia Antipolis, Ct Hospitalier Universitaire Nice filed Critical Univ Nice Sophia Antipolis
Application granted granted Critical
Publication of DK2039356T3 publication Critical patent/DK2039356T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK08368017.3T 2007-09-20 2008-09-12 Spytfremmende præparat omfattende en M3-muskarinagonist og en alfa-2-adrenerg antagonist DK2039356T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706596A FR2921268B1 (fr) 2007-09-20 2007-09-20 Composition sialagogue

Publications (1)

Publication Number Publication Date
DK2039356T3 true DK2039356T3 (da) 2013-10-14

Family

ID=39190370

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08368017.3T DK2039356T3 (da) 2007-09-20 2008-09-12 Spytfremmende præparat omfattende en M3-muskarinagonist og en alfa-2-adrenerg antagonist

Country Status (6)

Country Link
EP (1) EP2039356B1 (da)
DK (1) DK2039356T3 (da)
ES (1) ES2430599T3 (da)
FR (1) FR2921268B1 (da)
PL (1) PL2039356T3 (da)
PT (1) PT2039356E (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012158580A2 (en) 2011-05-16 2012-11-22 Colgate-Palmolive Company Oral care compositions
RU2496469C2 (ru) * 2012-01-11 2013-10-27 Владимир Николаевич Иванов Безабразивная зубная паста, содержащая фермент папаин, экстракт сфагнума, натрий-кальциевую соль сополимера полиметилвинилового спирта и малеиновой кислоты, d,l-пирролидонкарбоксилат n-кокоил этиларгината и натрия фторид
RU2487698C1 (ru) * 2012-01-11 2013-07-20 Сергей Борисович Улитовский Безабразивная зубная паста, содержащая фермент папаин, экстракт гарпагофитума, d,l-пирролидонкарбоксилат n-кокоил этиларгината и натрия фторид

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007064755A2 (en) * 2005-11-30 2007-06-07 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant

Also Published As

Publication number Publication date
EP2039356A1 (fr) 2009-03-25
PL2039356T3 (pl) 2014-03-31
EP2039356B1 (fr) 2013-07-10
FR2921268B1 (fr) 2010-02-26
FR2921268A1 (fr) 2009-03-27
PT2039356E (pt) 2013-10-23
ES2430599T3 (es) 2013-11-21

Similar Documents

Publication Publication Date Title
DK2313111T3 (da) Toll-lignende receptoragonistformuleringer og anvendelse deraf
CY2018017I2 (el) Συνδυασμοι ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα-2 αδρενεργικου υποδοχεα
BRPI1014877A8 (pt) compostos diamida tendo antagonista do receptor muscarínico e atividade agonista do receptor b2 adrenérgico.
SMT201500120B (it) Agenti di legame di notch e antagonisti di notch emetodi per il loro uso
EP2120575A4 (en) AGONISTS AND ANTAGONISTS OF SPHINGOSINE-1-PHOSPHATE RECEPTORS
ATE531710T1 (de) Piperidin-gpcr-agonisten
LT3508477T (lt) C5ar antagonistai
DK2139890T3 (da) Perifere opioidreceptor-antagonister og anvendelser deraf
ATE517103T1 (de) Piperidin-gpcr-agonisten
BRPI0813580A2 (pt) Antagonistas de receptor 1 de hormônio de concentração de melanina não básicos e métodos
HRP20151108T1 (xx) Antagonisti nogo-receptora
DK1857457T3 (da) Benzimidazolderivat og dets anvendelse som All-receptor-antagonist
DK2252581T3 (da) Kappa-selektiv opioidreceptorantagonist
EP2079307A4 (en) Farnesoid X RECEPTOR AGONISTS
NO20092217L (no) Agonist TrkB antistoffer og anvendelser derav
ZA201001954B (en) Amine derivative having npy y5 receptor antagonist activity and use thereof
BRPI0808025A2 (pt) Composto de benzimidazol e uso farmacêutico do mesmo
BRPI0806966A2 (pt) Combinação de um antagonista de receptor muscarínico e um agonista beta-2-adrenoceptor
IL185726A0 (en) Benzimidazole derivative and use as angiotensin ii antagonist
HRP20160950T1 (hr) Polimorfi antagonista mglur5 receptora
DK2121630T3 (da) Hurtigt dissocierende dopamin-2-receptor-antagonister
DE602007001341D1 (de) Niederhaltevorrichtung in einer endappliziereinrichtung
DE602007004823D1 (de) Zusammensetzungen zur insektenbekämpfung
BRPI0918431A2 (pt) produto farmacêutico compreendendo um antagonista de receptor muscarínico e um agonista de beta-2-adrenoceptor.
BRPI0809032A2 (pt) Aparelho e método de franzimento de rede